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A Review of Bounding Biomedicine:  
Evidence and Rhetoric in the New Science of Alternative Medicine 
 
J. Blake Scott 
 
Bounding Biomedicine: Evidence and Rhetoric in the New Science of Alternative 
Medicine. By Colleen Derkatch. Chicago, IL: University of Chicago Press, 2016. 238 
pages. $55 cloth; $10 e-book. 
 
 
 Complementary and alternative medicine (CAM) is ubiquitous in U.S. healthcare 
practices. According to the most recent National Health Interview Survey in 2012, about 
59 million Americans spend out-of-pocket money on complementary health approaches 
(including for pain treatment) to the tune of $30.2 million per year 
(https://nccih.nih.gov/research/statistics/NHIS/2012/key-findings). Although not as far 
along, CAM’s acceptance by mainstream medicine has also increased, particularly given 
the need for alternative pain treatment brought by the opioid epidemic. The NIH’s 
National Center for Complementary and Integrative Health is busy sponsoring, 
conducting, and disseminating research designed to integrate CAM in biomedicine. The 
CDC has issued guidelines for using non-pharmacologic therapies as first-line treatment 
for chronic pain, and the AMA is urging insurance companies to cover such therapies. 
Fairly recently, Harvard University’s Osher Center for Integrative Medicine began 
promoting research published in the Journal of Alternative and Complementary 
Medicine. So how did this relationship between CAM and mainstream medicine develop? 
 Through its meticulous analysis of a crucial moment of rhetorical boundary 
marking, Colleen Derkatch’s Bounding Biomedicine provides the most in-depth answer 
to this question to date. Focusing on a 1998 cluster of themed articles in JAMA and 
JAMA-Archives specialty journals in which CAM was first taken up and scrutinized in 
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biomedical discourse, Bounding Biomedicine examines how medical professionals 
engaged in rhetorical boundary work that reinforced a hierarchical but also wavering 
distinction between mainstream medicine and CAM.  
 Uncovering the “self-concealing” (p. 193), purposeful, and persuasive moves in 
these articles in relation to their immediate historical context and intertextual responses, 
Bounding Biomedicine examines this landmark moment through multiple angles at once: 
the cultural context of consumer-driven healthcare and a paradigm of self health 
maintenance; growing professional anxiety over disciplinary status in biomedicine; the 
specific research, publication review, and other evaluative processes through which 
biomedicine attempted to regulate its boundaries; and the extended pattern of boundary 
marking played out in clinical practice and popular media reporting. Organized around 
the central question of “How does the notion of evidence determine the boundaries of 
biomedical, from expert to public contexts?” (p. 19, italics in original), the book’s 
chapters take readers through several dimensions of persuasive boundary negotiation 
involving CAM in the JAMA-Archives articles and their intertext, starting within 
biomedical research and then moving outward to implications for medical practice and 
for public understanding.  
 At the heart of the book, in chapters two and three, Derkatch provides a close 
textual analysis of the CAM-themed publications themselves, first explaining how they 
situate and define CAM as residual to biomedicine, and then examining how they 
evaluate CAM research in relation to randomized controlled trials and evidence-based 
medicine (and their specific notions of safety and efficacy). These chapters are where 
Derkatch offers her most incisive insights about biomedicine’s rhetorical boundary work, 
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demonstrating the usefulness of rhetorical analysis to this other knowledge-making 
domain. Although Derkatch’s merging of topos theory, rhetorical genre theory, and 
socio-rhetorical boundary theory is well suited to her analysis (especially in the book’s 
middle chapters), this analysis could be further informed by a multi-layered approach to 
stasis theory, particularly given the way definition, evaluation, and policy questions inter-
animate attempts to demarcate and maintain boundaries. Also part of the heart of the 
book, and particularly informed by Derkatch’s observations and interviews, chapter four 
provides the alternative perspective of CAM in clinical practice, which gets elided by 
mainstream biomedical research. In addition to raising questions about this research 
framework’s requirement of the placebo control and its ability to account for CAM’s 
effectiveness, this chapter offers a nuanced take on patient choice and agency, one that 
could inform ongoing “right to try” discourse and its proponents’ counter-assumptions 
about patient welfare. 
 In addition to its timely topical contribution, Bounding Biomedicine makes a 
groundbreaking methodological contribution to the rhetoric of health and medicine 
through its innovative variation of a rhetorical-cultural approach. In examining a 
contextualized historical moment of boundary negotiation from multiple perspectives, 
Derkatch shows how rhetorical analysis can be culturally informed and multi-angled but 
also focused and fine-grained. In this way, we could characterize the analytic method 
here as a merging of Leah Ceccarelli’s (2001)close textual-intertextual analysis in 
Shaping Science with Rhetoric and the rhetorical-cultural analysis I employ in Risky 
Rhetoric (2003). My only, minor critique is the seeming separation of these two impulses 
across the book, with chapters one and five offering cultural contextualization that could 
3
Scott: Book review: Bounding biomedicine
Published by STARS, 2020
be more integrated throughout (chapter four is perhaps where the two impulses best come 
together).   
 In addition to its “zoomed-in” rhetorical-cultural analysis, Bounding Biomedicine 
is impressive for the range of “texts” it brings together and examines through textual and 
qualitative methods; these texts include published research articles and also editorials and 
letters, discourse-based interviews with several types of health experts, interviews with 
patients seeking CAM, and media stories about CAM and biomedicine’s response to it. 
Such a triangulated research process reinforces Derkatch’s methodological innovation of 
examining a discrete rhetorical moment through multiple methods, source types, 
perspectives, and levels of analysis. This approach also enables Derkatch to enact what 
she calls a “descriptive” analysis (p. 15) that adapts its methods, along with rhetorical 
theory (classical, modern, and contemporary), to the dynamics of the rhetorical practices 
under study.  
 Along with its deep engagement with the texts and practices surrounding the 
JAMA-Archives boundary-defining moment, Bounding Biomedicine zooms back out to 
ask important larger questions about how we value medical knowledge-making and 
practice; these include the “prior question” of what models of research and practice 
reveal about “how we think medicine happens,” or should happen (p. 191, italics in 
original), as well as the question of how ‘“Wellness’ has become…an illness in waiting,” 
positioning those participating in CAM “into a realm defined…by dysfunction” (p. 196, 
italics in original) and self-regulation of health. These are the kinds of big questions 
rhetorical analysis can raise and explore for health and medicine’s varied stakeholders.  
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 In some ways a successor of Mary M. Lay Schuster’s The Rhetoric of Midwifery 
(2000), which also examines anxieties around and challenges to professional-medical 
borders, Bounding Biomedicine contributes to our understanding of the still-evolving 
relationship between traditional medicine and CAM, limited by, but also challenging, the 
former’s values and boundaries. Through its questions, methodology, and insights, this 
book can also more broadly shape our understanding of other attempts to re-negotiate 
biomedical boundaries; these include attempts to medicalize under-recognized illnesses, 
elevate the standing of marginalized practitioners, and better account for patients’ 
experiential knowledge in medical research and regulatory processes.  
 Bounding Biomedicine contributes what Judy Segal (2005) calls “useful 
knowledge” to rhetoricians and to biomedical researchers and practitioners, especially 
those with roles in publication and other gatekeeping forums. Beyond a better 
understanding of the values and assumptions, functions, and effects of rhetorical 
boundary making, though, Derkatch’s book offers ameliorative cautions about how 
narrow and self-reinforcing frameworks of biomedical value (as terministic screens) can 
shape healthcare in limiting ways, and, at the same time, how assumptions about patient 
choice and empowerment can look past important considerations of safety and efficacy 
(even if more broadly defined).  
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